Cambridge, United Kingdom

Alan Yin Kai Lau

This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent. Top assignee: Kudos Pharmaceuticals Limited. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alan Yin Kai Lau. Retrieved from https://idiyas.com/inventor/alan-yin-kai-lau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alan Yin Kai Lau: Innovator in Pharmaceutical Compounds

Introduction

Alan Yin Kai Lau is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on ATM inhibitors. His research and inventions have the potential to impact various therapeutic areas.

Latest Patents

Alan holds a patent for a compound related to ATM inhibitors. The application concerns a compound of formula I, wherein one of P and Q is O, and the other of P and Q is CH. This compound features a double bond between whichever of Q and P is CH and the carbon atom bearing the R group. This invention showcases his expertise in developing novel pharmaceutical compounds.

Career Highlights

Alan is currently associated with Kudos Pharmaceuticals Limited, where he continues to advance his research and development efforts. His work at the company reflects his commitment to innovation in the pharmaceutical industry.

Collaborations

Alan has collaborated with several professionals in his field, including Graeme Cameron, Murray Smith, and Niall Morrison Barr Martin. These collaborations enhance the scope and impact of his research.

Conclusion

Alan Yin Kai Lau is a distinguished inventor whose work on ATM inhibitors exemplifies the intersection of innovation and pharmaceutical science. His contributions are paving the way for future advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…